Leerink Swann downgraded Transcept Pharmaceuticals (NASDAQ: TSPT) from Outperform to Market Perform with a price target of $4-$4.50 (from $7-$8).
This article: 128 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE